The COVID vaccines currently being deployed were
developed with unprecedented speed, but the mRNA technology at work
in some of them is an equally impressive success story. Because any
desired mRNA sequence can be synthesized in massive quantities, one
of the biggest hurdles in a variety of mRNA therapies is the
ability to package those sequences into the lipid nanoparticles
that deliver them into cells.
New microfluidic device delivers mRNA nanoparticles a
hundred times faster
